Caliway Biopharmaceuticals Co Ltd banner

Dividends

Caliway Biopharmaceuticals Co Ltd
does not pay dividends

Shareholder Yield

Current shareholder yield for Caliway Biopharmaceuticals Co Ltd is .

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Caliway Biopharmaceuticals Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Caliway Biopharmaceuticals Co Ltd

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

Price
Caliway Biopharmaceuticals Co Ltd

Annual Price Range
66.6
52w Low
65.4
52w High
183
Price Metrics
Average Annual Return 132.2%
Standard Deviation of Annual Returns 129.86%
Max Drawdown -100%
Shares Statistics
Market Capitalization 103.6B TWD
Shares Outstanding 1 557 200 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

Caliway Biopharmaceuticals Co Ltd's latest stock split occurred on Jul 14, 2025

The company executed a 10-for-1 stock split, meaning that for every share held, investors received 10 new shares.

Before the split, Caliway Biopharmaceuticals Co Ltd traded at 121.5 per share. Afterward, the share price was about 121.5.

The adjusted shares began trading on Jul 14, 2025. This was the only stock split in Caliway Biopharmaceuticals Co Ltd's history.

Pre-Split Price
121.5 121.5
Post-Split Price
121.5
Before
After